Oracle Process Manufacturing Regulatory Management up to 12.2.15 Internal Operations privilege escalation
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.3 | $5k-$25k | 0.00+ |
Summary
A vulnerability, which was classified as critical, has been found in Oracle Process Manufacturing Regulatory Management up to 12.2.15. The impacted element is an unknown function of the component Internal Operations. The manipulation leads to Remote Privilege Escalation. This vulnerability is documented as CVE-2026-60681. The attack can be initiated remotely. There is not any exploit available.
Details
A vulnerability was found in Oracle Process Manufacturing Regulatory Management up to 12.2.15 and classified as critical. This issue affects an unknown functionality of the component Internal Operations. The manipulation with an unknown input leads to a remote privilege escalation vulnerability. Impacted is confidentiality, integrity, and availability. The summary by CVE is:
Vulnerability in the Oracle Process Manufacturing Regulatory Management product of Oracle E-Business Suite (component: Internal Operations). Supported versions that are affected are 12.2.3-12.2.15. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Oracle Process Manufacturing Regulatory Management. Successful attacks of this vulnerability can result in takeover of Oracle Process Manufacturing Regulatory Management. CVSS 3.1 Base Score 8.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H).
The advisory is shared at oracle.com. The identification of this vulnerability is CVE-2026-60681 since 07/08/2026. The exploitation is known to be easy. The attack may be initiated remotely. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $5k-$25k at the moment (estimation calculated on 07/22/2026).
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Vendor
Name
Version
- 12.2.0
- 12.2.1
- 12.2.2
- 12.2.3
- 12.2.4
- 12.2.5
- 12.2.6
- 12.2.7
- 12.2.8
- 12.2.9
- 12.2.10
- 12.2.11
- 12.2.12
- 12.2.13
- 12.2.14
- 12.2.15
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.3VulDB Meta Temp Score: 6.3
VulDB Base Score: 6.3
VulDB Temp Score: 6.3
VulDB Vector: 🔒
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Privilege escalationCWE: Unknown
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔒
Timeline
07/08/2026 CVE reserved07/22/2026 Advisory disclosed
07/22/2026 VulDB entry created
07/22/2026 VulDB entry last update
Sources
Vendor: oracle.comAdvisory: oracle.com
Status: Confirmed
CVE: CVE-2026-60681 (🔒)
GCVE (CVE): GCVE-0-2026-60681
GCVE (VulDB): GCVE-100-381641
Entry
Created: 07/22/2026 04:37Changes: 07/22/2026 04:37 (51)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.